Literature DB >> 27637460

Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.

Minju Song1, Abdullah Alshaikh1, Terresa Kim1, Sol Kim1, Michelle Dang1, Shebli Mehrazarin1, Ki-Hyuk Shin2, Mo Kang2, No-Hee Park3, Reuben H Kim4.   

Abstract

INTRODUCTION: Surgical interventions such as tooth extraction increase the chances of developing osteonecrosis of the jaw in patients receiving bisphosphonates (BPs) for the treatment of bone-related diseases. Tooth extraction is often performed to eliminate preexisting pathological inflammatory conditions that make the tooth unsalvageable; however, the role of such conditions on bisphosphonate-related osteonecrosis of the jaw (BRONJ) development after tooth extraction is not clearly defined. Here, we examined the effects of periapical periodontitis on tooth extraction-induced BRONJ development in mice.
METHODS: Periapical periodontitis was induced by exposing the pulp of the maxillary first molar for 3 weeks in C57/BL6 mice that were intravenously administered with BPs. The same tooth was extracted, and after an 3 additional weeks, the mice were harvested for histologic, histomorphometric, and histochemical staining analyses.
RESULTS: Pulp exposure induced periapical radiolucency as shown by increased inflammatory cells, tartrate-resistant acid phosphatase-positive osteoclasts, and bone resorption. When BPs were administered, pulp exposure did not induce apical bone resorption despite the presence of inflammatory cells and tartrate-resistant acid phosphatase-positive osteoclasts. Although tooth extraction alone induced BRONJ lesions, pulp exposure further increased tooth extraction-induced BRONJ development as shown by the presence of more bone necrosis.
CONCLUSIONS: Our study demonstrates that a preexisting pathological inflammatory condition such as periapical periodontitis is a predisposing factor that may exacerbate BRONJ development after tooth extraction. Our study further provides a clinical implication wherein periapical periodontitis should be controlled before performing tooth extraction in BP users in order to reduce the risk of developing BRONJ.
Copyright © 2016 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bisphosphonate; bisphosphonate-related osteonecrosis of the jaw; inflammation; periapical periodontitis; tooth extraction

Mesh:

Substances:

Year:  2016        PMID: 27637460      PMCID: PMC5085836          DOI: 10.1016/j.joen.2016.07.020

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  24 in total

1.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

2.  Osteonecrosis of the jaw and oral bisphosphonate treatment.

Authors:  John B Nase; Jon B Suzuki
Journal:  J Am Dent Assoc       Date:  2006-08       Impact factor: 3.634

3.  RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease.

Authors:  Tara L Aghaloo; Simon Cheong; Olga Bezouglaia; Paul Kostenuik; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

Review 4.  On the causes of persistent apical periodontitis: a review.

Authors:  P N R Nair
Journal:  Int Endod J       Date:  2006-04       Impact factor: 5.264

Review 5.  Periapical inflammatory responses and their modulation.

Authors:  P Stashenko; R Teles; R D'Souza
Journal:  Crit Rev Oral Biol Med       Date:  1998

6.  Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.

Authors:  Ben Kang; Simon Cheong; Thawinee Chaichanasakul; Olga Bezouglaia; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

7.  Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.

Authors:  Drake W Williams; Cindy Lee; Terresa Kim; Hideo Yagita; Hongkun Wu; Sil Park; Paul Yang; Honghu Liu; Songtao Shi; Ki-Hyuk Shin; Mo K Kang; No-Hee Park; Reuben H Kim
Journal:  Am J Pathol       Date:  2014-08-28       Impact factor: 4.307

8.  Giant osteoclast formation and long-term oral bisphosphonate therapy.

Authors:  Robert S Weinstein; Paula K Roberson; Stavros C Manolagas
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

9.  Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.

Authors:  F Saad; J E Brown; C Van Poznak; T Ibrahim; S M Stemmer; A T Stopeck; I J Diel; S Takahashi; N Shore; D H Henry; C H Barrios; T Facon; F Senecal; K Fizazi; L Zhou; A Daniels; P Carrière; R Dansey
Journal:  Ann Oncol       Date:  2011-10-10       Impact factor: 32.976

10.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

View more
  19 in total

1.  Anti-vascular endothelial growth factor antibody monotherapy causes destructive advanced periodontitis in rice rats (Oryzomys palustris).

Authors:  J G Messer; E J Castillo; A M Abraham; J M Jiron; R Israel; J F Yarrow; S Thomas; M C Reynolds; R D Wnek; M Jorgensen; N Wanionok; C Van Poznak; I Bhattacharyya; D B Kimmel; J I Aguirre
Journal:  Bone       Date:  2019-11-07       Impact factor: 4.398

2.  Long-Term Ligature-Induced Periodontitis Exacerbates Development of Bisphosphonate-Related Osteonecrosis of the Jaw in Mice.

Authors:  Drake Winslow Williams; Katie Ho; Allison Lenon; Sol Kim; Terresa Kim; Yousang Gwack; Reuben H Kim
Journal:  J Bone Miner Res       Date:  2022-06-09       Impact factor: 6.390

3.  Clastic cells are absent around the root surface in pulp-exposed periapical periodontitis lesions in mice.

Authors:  A Shah; D Lee; M Song; S Kim; M K Kang; R H Kim
Journal:  Oral Dis       Date:  2018-03       Impact factor: 3.511

4.  Clinically Relevant Doses of Sclerostin Antibody Do Not Induce Osteonecrosis of the Jaw (ONJ) in Rats with Experimental Periodontitis.

Authors:  Danny Hadaya; Ioannis Gkouveris; Akrivoula Soundia; Olga Bezouglaia; Rogely W Boyce; Marina Stolina; Denise Dwyer; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2018-09-24       Impact factor: 6.741

Review 5.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

6.  Removal of Pre-Existing Periodontal Inflammatory Condition before Tooth Extraction Ameliorates Medication-Related Osteonecrosis of the Jaw-Like Lesion in Mice.

Authors:  Terresa Kim; Sol Kim; Minju Song; Cindy Lee; Hideo Yagita; Drake W Williams; Eric C Sung; Christine Hong; Ki-Hyuk Shin; Mo K Kang; No-Hee Park; Reuben H Kim
Journal:  Am J Pathol       Date:  2018-07-27       Impact factor: 5.770

7.  Deficiency of the SMOC2 matricellular protein impairs bone healing and produces age-dependent bone loss.

Authors:  Supawich Morkmued; François Clauss; Brigitte Schuhbaur; Valérie Fraulob; Eric Mathieu; Joseph Hemmerlé; Hans Clevers; Bon-Kyoung Koo; Pascal Dollé; Agnès Bloch-Zupan; Karen Niederreither
Journal:  Sci Rep       Date:  2020-09-09       Impact factor: 4.379

Review 8.  Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials.

Authors:  Henrik Holtmann; Julian Lommen; Norbert R Kübler; Christoph Sproll; Majeed Rana; Patrick Karschuck; Rita Depprich
Journal:  J Int Med Res       Date:  2018-08-09       Impact factor: 1.671

Review 9.  Inflammasomes in Alveolar Bone Loss.

Authors:  Yang Li; Junqi Ling; Qianzhou Jiang
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

Review 10.  Clinical impact of bisphosphonates in root canal therapy.

Authors:  Mothanna K AlRahabi; Hani M Ghabbani
Journal:  Saudi Med J       Date:  2018-03       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.